Urologix Reports 59% Increase in Revenue Year-Over-Year for Fiscal 2012 Third Quarter
MINNEAPOLIS, April 26, 2012 (GLOBE NEWSWIRE) -- Urologix®, Inc. (Nasdaq:ULGX), the leading provider of in-office procedures for the safe, durable and effective treatment of BPH, today reported financial results for its fiscal third quarter ended March 31, 2012.